These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Depression and Parkinson's disease. Mayeux R; Stern Y; Williams JB; Sano M; Cote L Adv Neurol; 1987; 45():451-5. PubMed ID: 2435113 [No Abstract] [Full Text] [Related]
7. Hormonal responses to fenfluramine in depressive subtypes. Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137 [TBL] [Abstract][Full Text] [Related]
8. [Towards an attempt at biological differentiation of endogenous and exogenous depression: a study of beta-endorphins and other parameters (prolactin, growth hormone and dexamethasone repression test) in a cohort of ambulatory depressed patients]. Gallart JM; Galard R; Catalan R; Arguello JM; Castellanos JM; Schwartz S Ann Med Psychol (Paris); 1988; 146(8):758-63. PubMed ID: 2977276 [No Abstract] [Full Text] [Related]
9. Hormonal responses to dextroamphetamine in depressed and normal adolescents. Waterman GS; Ryan ND; Puig-Antich J; Meyer V; Ambrosini PJ; Rabinovich H; Stull S; Novacenko H; Williamson DE; Nelson B J Am Acad Child Adolesc Psychiatry; 1991 May; 30(3):415-22. PubMed ID: 2055877 [TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine predictors of electroconvulsive therapy outcome. Dexamethasone suppression test and prolactin. Fink M Ann N Y Acad Sci; 1986; 462():30-6. PubMed ID: 3518572 [No Abstract] [Full Text] [Related]
11. Neuroendocrine challenges in the diagnosis of depressive disorders. López-Ibor JJ; Saiz-Ruiz J; Moral Iglesias L Br J Psychiatry Suppl; 1989 May; (4):73-6. PubMed ID: 2605013 [No Abstract] [Full Text] [Related]
12. Endocrine responses after thyrotrophin-releasing hormone stimulation and dexamethasone suppression tests in the major depressive syndrome. Aalbers C; Taljaard JJ; Gagiano CA S Afr Med J; 1986 Oct; 70(8):464-8. PubMed ID: 3095937 [TBL] [Abstract][Full Text] [Related]
13. The use of the dexamethasone suppression test in the evaluation of depression: a re-examination. Bielski RJ; Holmes GA; West CL; Shafer CL J Am Osteopath Assoc; 1987 Apr; 87(4):302-5. PubMed ID: 3583846 [No Abstract] [Full Text] [Related]
14. Dexamethasone suppression test and subcategories of DSM-III major depression. Kitamura T; Shima S; Shikano T; Kano S; Asai M; Itoh H Psychopathology; 1985; 18(4):198-200. PubMed ID: 4089118 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of amoxapine in psychotic depression. Anton RF; Sexauer JD Am J Psychiatry; 1983 Oct; 140(10):1344-7. PubMed ID: 6624968 [TBL] [Abstract][Full Text] [Related]
16. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339 [TBL] [Abstract][Full Text] [Related]
17. [Laboratory diagnosis of depressive disorders]. Linkowski P Rev Med Brux; 1983 Apr; 4(4):229-33. PubMed ID: 6410481 [No Abstract] [Full Text] [Related]
18. Reversal of dexamethasone nonsuppression with sleep deprivation in primary depression. Nasrallah HA; Kuperman S; Coryell W Am J Psychiatry; 1980 Nov; 137(11):1463-4. PubMed ID: 7435693 [No Abstract] [Full Text] [Related]
19. The specificity of the dexamethasone suppression test in endogenous depressive patients. Lu RB; Ho SL; Huang HC; Lin YT Neuropsychopharmacology; 1988 May; 1(2):157-62. PubMed ID: 3251496 [TBL] [Abstract][Full Text] [Related]
20. Preliminary data on the dexamethasone suppression test in children with major depressive disorder. Geller B; Rogol AD; Knitter EF Am J Psychiatry; 1983 May; 140(5):620-2. PubMed ID: 6846596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]